Literature DB >> 33868656

LI-RADS: Future Directions.

Victoria Chernyak1, Claude B Sirlin2.   

Abstract

Year:  2021        PMID： 33868656      PMCID： PMC8043702          DOI： 10.1002/cld.1034

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  11 in total

1.  Differing Interpretations of Report Terminology Between Primary Care Physicians and Radiologists.

Authors:  Andrew J Gunn; Mitch C Tuttle; Efren J Flores; Mark D Mangano; Susan E Bennett; Dushyant V Sahani; Garry Choy; Giles W Boland
Journal:  J Am Coll Radiol       Date:  2016-08-30       Impact factor: 5.532

2.  The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma.

Authors:  Mohammad Chaudhry; Katrina A McGinty; Benjamin Mervak; Reginald Lerebours; Cai Li; Erin Shropshire; James Ronald; Leah Commander; Johann Hertel; Sheng Luo; Mustafa R Bashir; Lauren M B Burke
Journal:  Radiology       Date:  2019-12-17       Impact factor: 11.105

3.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors:  Jorge A Marrero; Laura M Kulik; Claude B Sirlin; Andrew X Zhu; Richard S Finn; Michael M Abecassis; Lewis R Roberts; Julie K Heimbach
Journal:  Hepatology       Date:  2018-08       Impact factor: 17.425

4.  Clinicians and surgeon survey regarding current and future versions of CT/MRI LI-RADS.

Authors:  Abdullah O Alenazi; Khaled M Elsayes; Robert M Marks; Joseph H Yacoub; Elizabeth M Hecht; Victoria Chernyak; Satheesh Krishna; Venkatesh Surabhi; James T Lee; Ryan Ash; Irene Cruite; Ania Z Kielar
Journal:  Abdom Radiol (NY)       Date:  2020-08

5.  Dynamic contrast-enhanced MRI to assess hepatocellular carcinoma response to Transarterial chemoembolization using LI-RADS criteria: A pilot study.

Authors:  Alana Thibodeau-Antonacci; Léonie Petitclerc; Guillaume Gilbert; Laurent Bilodeau; Damien Olivié; Milena Cerny; Hélène Castel; Simon Turcotte; Catherine Huet; Pierre Perreault; Gilles Soulez; Miguel Chagnon; Samuel Kadoury; An Tang
Journal:  Magn Reson Imaging       Date:  2019-06-25       Impact factor: 2.546

Review 6.  Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.

Authors:  Victoria Chernyak; Kathryn J Fowler; Aya Kamaya; Ania Z Kielar; Khaled M Elsayes; Mustafa R Bashir; Yuko Kono; Richard K Do; Donald G Mitchell; Amit G Singal; An Tang; Claude B Sirlin
Journal:  Radiology       Date:  2018-09-25       Impact factor: 11.105

7.  Interpretive Differences Between Patients and Radiologists Regarding the Diagnostic Confidence Associated With Commonly Used Phrases in the Radiology Report.

Authors:  Marina I Mityul; Brian Gilcrease-Garcia; Adam Searleman; Jennifer L Demertzis; Andrew J Gunn
Journal:  AJR Am J Roentgenol       Date:  2017-10-12       Impact factor: 3.959

8.  Nonstandardized Terminology to Describe Focal Liver Lesions in Patients at Risk for Hepatocellular Carcinoma: Implications Regarding Clinical Communication.

Authors:  Michael T Corwin; Andrew Y Lee; Ghaneh Fananapazir; Thomas W Loehfelm; Souvik Sarkar; Claude B Sirlin
Journal:  AJR Am J Roentgenol       Date:  2017-10-12       Impact factor: 3.959

9.  LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy.

Authors:  Erin L Shropshire; Mohammad Chaudhry; Chad M Miller; Brian C Allen; Erol Bozdogan; Diana M Cardona; Lindsay Y King; Gemini L Janas; Richard K Do; Charles Y Kim; James Ronald; Mustafa R Bashir
Journal:  Radiology       Date:  2019-04-30       Impact factor: 29.146

10.  Performance of LI-RADS version 2018 CT treatment response algorithm in tumor response evaluation and survival prediction of patients with single hepatocellular carcinoma after radiofrequency ablation.

Authors:  Yun Zhang; Jinju Wang; Hui Li; Tianying Zheng; Hanyu Jiang; Mou Li; Bin Song
Journal:  Ann Transl Med       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.